株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マウスモデルの世界市場 2021年までの予測:種類 (近交系、ノックアウト、ハイブリッド)、技術 (CRISPR、マイクロインジェクション)、用途、サービス別

Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021

発行 MarketsandMarkets 商品コード 293088
出版日 ページ情報 英文 271 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.99円で換算しております。
Back to Top
マウスモデルの世界市場 2021年までの予測:種類 (近交系、ノックアウト、ハイブリッド)、技術 (CRISPR、マイクロインジェクション)、用途、サービス別 Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021
出版日: 2017年02月21日 ページ情報: 英文 271 Pages
概要

人間とマウスの生体構造、生理学および遺伝的特徴には顕著な類似点があることから、人間の疾患プロセスを解明することができるため、マウスモデルは研究活動において必須なツールとなっています。マウスモデルはその小ささ、短い世代時間、加速的生涯、低コスト、省スペースというメリットのおかげで最もよく使われ、薬物療法の研究開発を促進する要因となっています。世界のマウスモデルの市場規模は、2016年には11億1000万米ドル、2021年には15億9000万米ドルと、7.5%のCAGR (複合年間成長率) で成長する見通しです。

当レポートでは、世界のマウスモデル市場を取り上げ、市場を大きくマウスモデルの市場とサービスの市場に区分し、タイプ別・技術別・疾患別・サービス別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめるなどした結果をお届けいたします。

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場のダイナミクス
    • 促進要因
      • マウスモデルの継続的な技術開発
        • 免疫診断・がん・難病向けマウスモデル
      • 個別化医療の市場拡大に伴う、ヒト化マウスモデルの需要増大
      • 製薬企業の研究開発 (R&D) 活動の活発化
      • ES細胞およびノックアウト/突然変異マウスの開発に対する、国際学会での関心の増大
    • 抑制要因
      • ラットモデルの利用増加
      • 冷凍保存の恩恵の増大
      • 研究目的での動物利用に関する規制・法令
    • 市場機会
      • CRISPRの登場:生体医学研究の分野での強力なツール
      • ヒト化マウスモデルの需要拡大
      • モノクローナル抗体の生産拡大
    • 課題
      • 動物実験の代替手段の開発
      • ゼブラフィッシュモデルの開発の進展
      • マウスモデル改善の必要性

第6章 世界各国の監督体制

第7章 臨床研究の評価

  • イントロダクション
  • 臨床研究
  • 臨床研究の評価

第8章 マウスモデル市場:種類別

  • イントロダクション
  • 近交系マウス
  • 非近交系マウス
  • 遺伝子組み換えマウス
  • ハイブリッドマウス/コンジェニック (類遺伝子) マウス
  • 条件付き/外科的修復済みマウス
  • 自然発生的な突然変異マウス

第9章 マウスモデル市場:サービス別

  • イントロダクション
  • 繁殖 (ブリーディング)
  • 冷凍保存
  • 検疫
  • 再導出
  • モデル・インライセンシング
  • 遺伝子検査
  • その他

第10章 マウスモデル市場:技術別

  • イントロダクション
  • CRISPR/CAS9
  • マイクロインジェクション
  • ES細胞注射
  • 核移植
  • その他の技術
    • SMGT (遺伝子組み換え型・精子媒介遺伝子伝達)
    • ウイルス/ベクター媒介遺伝子伝達
    • 遺伝子銃
    • TALEN/ZFN

第11章 マウスモデル市場:用途別

  • イントロダクション
  • がん (腫瘍) 研究
  • 免疫疾患・炎症研究
  • 糖尿病研究
  • 心血管疾患研究
  • 中枢神経系 (CNS) 研究
  • その他の疾患の研究

第12章 マウス飼育用品市場:種類別

  • イントロダクション
  • かご
  • 飼料
  • 寝床
  • その他の飼育用品 (ケア用品)

第13章 マウスモデル市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • その他
  • 他の国々 (RoW)

第14章 競争環境

  • 概要
  • 市場シェア分析:マウスモデル市場
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • THE JACKSON LABORATORY
    • TACONIC BIOSCIENCES, INC.
    • ENVIGO (HARLAN LABORATORIES, INC.)
  • 競争状況と動向
    • 事業連携・事業協力・協定・パートナーシップ・合弁事業
    • 資金提供
    • 事業拡張
    • 新製品の発売
    • 企業買収
    • ライセンス取引
    • その他

第15章 企業プロファイル

  • イントロダクション
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • THE JACKSON LABORATORY
  • TACONIC BIOSCIENCES, INC.
  • ENVIGO
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • JANVIER LABS
  • HARBOUR ANTIBODIES BV (HARBOUR BIOMEDの子会社)
  • TRANS GENIC, INC.
  • GENOWAY
  • HORIZON DISCOVERY GROUP PLC (SAGE LABS, INC.)
  • INGENIOUS TARGETING LABORATORY

第16章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2192

Mice models are indispensable in research activities dealing with human disease processes due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. Mice models are the most popularly used animal models due to their small size, short generation time, accelerated lifespan, low cost, and requirement of less space. These factors help in accelerating the research and development of drug therapies. The mice model market is projected to reach USD 1.59 billion by 2021 from USD 1.11 billion in 2016, at a CAGR of 7.5% in the next five years (2016 to 2021).

The market players are continuously focusing on innovations in mice models for research on various human diseases. The major factor driving the growth of the market is the growing innovations and advances in mice models providing increased options to researchers to conduct research activities in particular diseases. Even the popularity of technologies like CRISPR, used in creating gene knockouts, is expected to be a major growth opportunity for the market.

On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the mice model market to some extent. In addition, increased benefits from cryopreservation, and regulations & laws for the ethical use of animals are some factors expected to restrain the growth of the market. Moreover, the continuous need for improved mice models, advancements in zebrafish model development, and alternative methods to animal testing is some of the major challenges for the market.

In 2016, the inbred mice are estimated to account for the largest share of the market, by type while genetically engineered mice models are expected to be the fastest-growing market segment, owing to high investments in the development of new and innovative knockout models that also increases the application areas for the models.

In 2016, North America is expected to account for the largest share of the market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America's large share is attributed to the rising demands for monoclonal antibody production, continued and responsible use of animals ensured by animal care organizations, rising preclinical activities by CROs and pharmaceutical companies, growing stem cell research in Canada, and government support for the development of protein drugs in Canada.

The major players focus on various strategies like agreements, partnerships, joint ventures, collaborations, expansions, product launches, funds/grants, licensing, and acquisitions to increase market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the models and services offered by top players in the mice model market. The report analyzes the mice model market, by type, technology, application, service, and mice care products.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the mice model market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for mice models & services across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the mice model market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the mice model market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. MICE MODEL: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: GLOBAL MICE CARE PRODUCTS MARKET, BY TYPE
  • 4.3. GLOBAL MICE MODEL MARKET, BY TECHNOLOGY, 2016 VS. 2021
  • 4.4. REGIONAL SNAPSHOT OF THE GLOBAL MICE MODEL MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Ongoing innovations in mice models
        • 5.2.1.1.1. Mice models for immune diseases
        • 5.2.1.1.2. Mice models for cancer
        • 5.2.1.1.3. Mice models for rare diseases
      • 5.2.1.2. Growing consumption of personalized medicine driving the demand for humanized mice models
      • 5.2.1.3. Continuous support in the form of grants and investments
      • 5.2.1.4. Growing number of pharmaceutical R&D activities
      • 5.2.1.5. Increasing focus of associations on the development of embryonic stem cells as well as knockout and mutant mice
        • 5.2.1.5.1. International Mouse Phenotyping Consortium (IMPC)
        • 5.2.1.5.2. International Knockout Mouse Consortium (IKMC)
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Growing use of rat models
      • 5.2.2.2. Increased benefits from cryopreservation
      • 5.2.2.3. Regulations and laws for ethical use of animals in research
        • 5.2.2.3.1. The Animal Welfare Act
        • 5.2.2.3.2. Public Health Service Policy on Humane Care and Use of Laboratory Animals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emergence of CRISPR as a powerful tool in the field of biomedical research
      • 5.2.3.2. Rising demand for humanized mice models
      • 5.2.3.3. Increase in monoclonal antibody production
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Development of alternative methods to animal testing
      • 5.2.4.2. Advancements in zebrafish model development
      • 5.2.4.3. Growing need for improved mice models

6. REGULATORY ASSESSMENT

  • 6.1. INTRODUCTION
  • 6.2. NORTH AMERICA
  • 6.3. EUROPE
  • 6.4. CHINA
  • 6.5. JAPAN
  • 6.6. INDIA
  • 6.7. AUSTRALIA
  • 6.8. BRAZIL

7. CLINICAL STUDIES ASSESSMENT

  • 7.1. INTRODUCTION
  • 7.2. CLINICAL STUDIES
  • 7.3. CLINICAL STUDIES ASSESSMENT

8. MICE MODEL MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. INBRED MICE
  • 8.3. OUTBRED MICE
  • 8.4. GENETICALLY ENGINEERED MICE
  • 8.5. HYBRID/CONGENIC MICE
  • 8.6. CONDITIONED/SURGICALLY MODIFIED MICE
  • 8.7. SPONTANEOUS MUTANT MICE

9. MICE MODEL MARKET, BY SERVICE

  • 9.1. INTRODUCTION
  • 9.2. BREEDING
  • 9.3. CRYOPRESERVATION
  • 9.4. QUARANTINE
  • 9.5. REDERIVATION
  • 9.6. MODEL IN-LICENSING
  • 9.7. GENETIC TESTING
  • 9.8. OTHER SERVICES

10. MICE MODEL MARKET, BY TECHNOLOGY

  • 10.1. INTRODUCTION
  • 10.2. CRISPR/CAS9
  • 10.3. MICROINJECTION
  • 10.4. EMBRYONIC STEM CELL INJECTION
  • 10.5. NUCLEAR TRANSFER
  • 10.6. OTHER TECHNOLOGIES
    • 10.6.1. GENETICALLY MODIFIED SPERM-MEDIATED GENE TRANSFER
    • 10.6.2. VIRUS/VECTOR-MEDIATED GENE TRANSFER
    • 10.6.3. LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA
    • 10.6.4. BIOLISTICS
    • 10.6.5. TALENS AND ZFNS

11. MICE MODEL MARKET, BY APPLICATION

  • 11.1. INTRODUCTION
  • 11.2. ONCOLOGY STUDIES
    • 11.2.1. CONTINUOUS GRANTS/FUNDS SUPPORTING CANCER RESEARCH STUDIES
    • 11.2.2. AGREEMENTS & COLLABORATIONS STRENGTHENING CANCER RESEARCH
    • 11.2.3. INTRODUCTION OF NEW MICE MODELS FOR SPECIFIC CANCERS
    • 11.2.4. EXPANSIONS SUPPORTING CANCER RESEARCH
  • 11.3. IMMUNOLOGY AND INFLAMMATION STUDIES
  • 11.4. DIABETES STUDIES
  • 11.5. CARDIOVASCULAR STUDIES
  • 11.6. CENTRAL NERVOUS SYSTEM (CNS) STUDIES
    • 11.6.1. GRANTS/FUNDS SUPPORTING NEUROLOGICAL RESEARCH
  • 11.7. OTHER DISEASE STUDIES

12. MICE CARE PRODUCTS MARKET, BY TYPE

  • 12.1. INTRODUCTION
  • 12.2. CAGES
  • 12.3. FEED
  • 12.4. BEDDING
  • 12.5. OTHER CARE PRODUCTS

13. MICE MODEL MARKET, BY REGION

  • 13.1. INTRODUCTION
  • 13.2. NORTH AMERICA
    • 13.2.1. U.S.
      • 13.2.1.1. Increased focus on biomedical research in the U.S.
      • 13.2.1.2. Rise in monoclonal antibody production to augment the use of mice models
      • 13.2.1.3. Increased activities by animal care organizations to create awareness on ethical usage of animals in research
      • 13.2.1.4. Development of biosimilars boosting the demand for preclinical services
      • 13.2.1.5. Nexus between CROs and pharmaceutical companies: outsourcing, partnerships to aid market growth
    • 13.2.2. CANADA
      • 13.2.2.1. Growth in stem cell research activities
      • 13.2.2.2. Government support for development of protein drugs
  • 13.3. EUROPE
    • 13.3.1. GERMANY
      • 13.3.1.1. Launch of Pro-Test Deutschland
      • 13.3.1.2. Growing biotechnology industry
    • 13.3.2. U.K.
      • 13.3.2.1. Demand for statistically robust results for animal studies
      • 13.3.2.2. Increase in cell therapy preclinical research
    • 13.3.3. FRANCE
      • 13.3.3.1. Funding for rare disease projects in France
    • 13.3.4. REST OF EUROPE (ROE)
      • 13.3.4.1. Rising usage of custom mice models in cancer research
      • 13.3.4.2. Events conducted by animal care associations to promote the ethical use of mice
      • 13.3.4.3. Rising focus on rare disease-related research
      • 13.3.4.4. Improving biomedical industry in Russia
      • 13.3.4.5. Growth in the biotech and pharma sector of Italy
      • 13.3.4.6. Sweden & Denmark: growing investments in research
  • 13.4. ASIA-PACIFIC
    • 13.4.1. CHINA
      • 13.4.1.1. Rising focus on precision medicine and personalized medicine
      • 13.4.1.2. International alliances for R&D activities
      • 13.4.1.3. Growing focus on pharmaceutical and mice model suppliers
      • 13.4.1.4. Public and private investments in China's life sciences sector
      • 13.4.1.5. Initiatives to reduce long approval times
      • 13.4.1.6. Intellectual property (IP) breaches, a challenge for market growth
    • 13.4.2. JAPAN
      • 13.4.2.1. Growth in biomedical and medical research
      • 13.4.2.2. Rising focus on life science research activities like regenerative medicine
    • 13.4.3. INDIA
      • 13.4.3.1. Development of bioclusters to boost India's biotechnology industry
      • 13.4.3.2. Rising R&D expenditure, an indicator of growth in research intensity
      • 13.4.3.3. Shifting of outsourcing preclinical activities from India towards European nations
      • 13.4.3.4. Limited infrastructural facilities in India
      • 13.4.3.5. Weak intellectual property protection
    • 13.4.4. REST OF ASIA-PACIFIC (ROAPAC)
      • 13.4.4.1. Influx of international players
      • 13.4.4.2. Ongoing biomedical research activities in Australia
      • 13.4.4.3. Rising translational and biomedical research in Singapore
      • 13.4.4.4. Increase in animal research in Malaysia
      • 13.4.4.5. Rising pharmaceutical and biotechnology R&D in Korea
    • 13.4.5. REST OF THE WORLD (ROW)
      • 13.4.5.1. Rising R&D in Brazilian pharmaceutical, biotechnology, and research industries to bolster market growth
      • 13.4.5.2. Growing pharmaceutical and biotechnology industries in Saudi Arabia and the UAE

14. COMPETITIVE LANDSCAPE

  • 14.1. OVERVIEW
  • 14.2. MICE MODEL MARKET: MARKET SHARE ANALYSIS (2015)
    • 14.2.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • 14.2.2. THE JACKSON LABORATORY
    • 14.2.3. TACONIC BIOSCIENCES, INC.
    • 14.2.4. ENVIGO (HARLAN LABORATORIES, INC.)
  • 14.3. COMPETITIVE SITUATION AND TRENDS
    • 14.3.1. ALLIANCES, COLLABORATIONS, AGREEMENTS, PARTNERSHIPS, AND JOINT VENTURES
    • 14.3.2. GRANTS & FUNDS
    • 14.3.3. EXPANSIONS
    • 14.3.4. PRODUCT LAUNCHES
    • 14.3.5. ACQUISITIONS
    • 14.3.6. LICENSING
    • 14.3.7. OTHERS

15. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 15.1. INTRODUCTION
  • 15.2. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 15.3. THE JACKSON LABORATORY
  • 15.4. TACONIC BIOSCIENCES, INC.
  • 15.5. ENVIGO
  • 15.6. LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 15.7. JANVIER LABS
  • 15.8. HARBOUR ANTIBODIES BV (A SUBSIDIARY OF HARBOUR BIOMED)
  • 15.9. TRANS GENIC, INC.
  • 15.10. GENOWAY
  • 15.11. HORIZON DISCOVERY GROUP PLC (SAGE LABS, INC.)
  • 15.12. INGENIOUS TARGETING LABORATORY

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies

16. APPENDIX

  • 16.1. DISCUSSION GUIDE
  • 16.2. OTHER DEVELOPMENTS (2013-2016)
    • 16.2.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • 16.2.2. THE JACKSON LABORATORY (JAX)
    • 16.2.3. TACONIC BIOSCIENCES INC.
    • 16.2.4. ENVIGO
    • 16.2.5. LABORATORY CORPORATION OF AMERICA HOLDINGS (COVANCE, INC.)
    • 16.2.6. TRANS GENIC, INC.
    • 16.2.7. GENOWAY
    • 16.2.8. HORIZON DISCOVERY GROUP PLC (SAGE LABS, INC.)
  • 16.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 16.5. AVAILABLE CUSTOMIZATIONS
  • 16.6. RELATED REPORTS
  • 16.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: SAMPLING FRAME: PRIMARY RESEARCH
  • TABLE 2: INDICATIVE LIST OF CLINICAL STUDIES CONDUCTED USING MICE MODELS
  • TABLE 3: GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: INBRED MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: OUTBRED MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: GENETICALLY ENGINEERED MICE (KNOCKOUT/KNOCKIN) MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: HYBRID/CONGENIC MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: SPONTANEOUS MUTANT MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 11: BREEDING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: CRYOPRESERVATION SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: QUARANTINE SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: REDERIVATION SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: MODEL IN LICENSING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: GENETIC TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 17: OTHER SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 18: GLOBAL MICE MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 19: MICE MODEL MARKET SIZE FOR CRISPR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: MICE MODEL MARKET SIZE FOR MICROINJECTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: MICE MODEL MARKET SIZE FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 22: MICE MODEL MARKET SIZE FOR NUCLEAR TRANSFER, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 23: MICE MODEL MARKET SIZE FOR OTHER TECHNOLOGIES, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 24: GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 25: INDICATIVE LIST OF RECENT CANCER RESEARCH STUDIES USING MICE MODELS
  • TABLE 26: MICE MODEL MARKET SIZE FOR ONCOLOGY STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MICE MODEL MARKET SIZE FOR IMMUNOLOGY AND INFLAMMATION STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 28: MICE MODEL MARKET SIZE FOR DIABETES STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 29: MICE MODEL MARKET SIZE FOR CARDIOVASCULAR STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 30: RECENT CNS DISORDER-RELATED RESEARCH STUDIES USING MICE MODELS
  • TABLE 31: MICE MODEL MARKET SIZE FOR CNS STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 32: MICE MODEL MARKET SIZE FOR OTHER DISEASE STUDIES, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL MICE CARE PRODUCTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 34: MICE CAGES MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 35: MICE FEED MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 36: MICE BEDDING MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 37: OTHER MICE CARE PRODUCTS MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 38: GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: MICE MODEL MARKET SIZE, BY CARE PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 45: NIH FUNDING FOR PROJECTS RELATED TO ANIMAL MODELS
  • TABLE 46: ASSOCIATIONS DIRECTLY RELATED TO THE ANIMAL MODEL MARKET
  • TABLE 47: ASSOCIATIONS INDIRECTLY RELATED TO THE ANIMAL MODEL MARKET
  • TABLE 48: U.S.: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: U.S.: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 50: U.S.: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 51: U.S.: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 52: CANADA: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: CANADA: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 54: CANADA: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 55: CANADA: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: MICE MODEL MARKET SIZE, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 62: GERMANY: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: GERMANY: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 64: GERMANY: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 65: GERMANY: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: U.K.: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: U.K.: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 68: U.K.: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 69: U.K.: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: FRANCE: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 71: FRANCE: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 72: FRANCE: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 73: FRANCE: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 74: EUROPEAN ANIMAL CARE ASSOCIATIONS AND THEIR EVENTS
  • TABLE 75: PHARMA 2020: IMPLEMENTATION
  • TABLE 76: ROE: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROE: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 78: ROE: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 79: ROE: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 83: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 84: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: ASIA-PACIFIC: MICE MODEL MARKET SIZE, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 86: CHINA: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: CHINA: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 88: CHINA: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 89: CHINA: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 90: JAPAN: SIGNIFICANT PARTNERSHIPS
  • TABLE 91: JAPAN: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: JAPAN: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 93: JAPAN: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 94: JAPAN: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: STUDY RESULTS REGARDING R&D EXPENDITURE OF 25 PHARMACEUTICAL COMPANIES
  • TABLE 96: INDIA: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: INDIA: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 98: INDIA: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 99: INDIA: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 100: ROAPAC: PLAYER ACTIVITY, 2013 TO 2015
  • TABLE 101: ROAPAC: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: ROAPAC: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 103: ROAPAC: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 104: ROAPAC: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: ROW: MICE MODEL MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 106: ROW: MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 107: ROW: MICE MODEL MARKET SIZE, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 108: ROW: MICE MODEL MARKET SIZE, BY APPLICATION, 2014-2021 (USD THOUSAND)
  • TABLE 109: ROW: MICE MODEL MARKET SIZE, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 110: ALLIANCES, COLLABORATIONS, AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS (2013-2016)
  • TABLE 111: GRANTS & FUNDS, 2013-2016
  • TABLE 112: KEY PLAYERS FOCUSING ON EXPANSIONS (2013-2016)
  • TABLE 113: PRODUCT LAUNCHES (2013-2016)
  • TABLE 114: ACQUISITIONS (2013-2016)
  • TABLE 115: LICENSING (2013-2016)
  • TABLE 116: KEY PLAYERS FOCUSING ON OTHER STRATEGIES (2013-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL MICE MODEL MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: MARKET FORECAST DESIGN
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL MICE MODEL MARKET, BY TECHNOLOGY (2016 VS. 2021)
  • FIGURE 8: GLOBAL MICE MODEL MARKET, BY TYPE (2016 VS. 2021)
  • FIGURE 9: GLOBAL MICE MODEL MARKET, BY SERVICE (2016 VS. 2021)
  • FIGURE 10: GLOBAL MICE MODEL MARKET, BY APPLICATION (2016 VS. 2021)
  • FIGURE 11: GLOBAL MICE CARE PRODUCTS MARKET, BY TYPE (2016 VS. 2021)
  • FIGURE 12: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: GROWING PHARMA R&D AND INCREASING FUNDING ARE EXPECTED TO DRIVE THE GLOBAL MICE MODEL MARKET DURING THE FORECAST PERIOD
  • FIGURE 14: NORTH AMERICA TO DOMINATE THE MICE CARE PRODUCTS MARKET IN 2016
  • FIGURE 15: CRISPR TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICE MODEL MARKET, BY TECHNOLOGY
  • FIGURE 16: ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MICE MODEL MARKET FROM 2016 TO 2021
  • FIGURE 17: MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: CLINICAL STUDIES USING MICE MODELS, BY INDICATION (2013 ONWARDS)
  • FIGURE 19: CLINICAL STUDIES USING MICE MODELS, BY COMPLETION (2013 ONWARDS)
  • FIGURE 20: CLINICAL STUDIES COMPLETION ESTIMATES PER YEAR (2014-2022)
  • FIGURE 21: GENETICALLY ENGINEERED MICE TO BE THE FASTEST-GROWING MICE MODEL MARKET SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 23: BREEDING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE MICE MODEL MARKET IN 2016
  • FIGURE 25: CRISPR TECHNOLOGY SEGMENT TO DOMINATE THE MICE MODEL TECHNOLOGY MARKET IN 2016
  • FIGURE 27: ONCOLOGY TO DOMINATE THE MICE MODEL MARKET IN 2016
  • FIGURE 28: CAGES ACCOUNTED FOR THE LARGEST SHARE OF THE MICE CARE PRODUCTS MARKET IN 2016
  • FIGURE 29: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR IN THE MICE MODEL MARKET DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
  • FIGURE 31: GERMANY TO DOMINATE THE EUROPEAN MICE MODEL MARKET IN 2016
  • FIGURE 32: NUMBER OF CELL THERAPY PRECLINICAL STUDIES LISTED IN THE PRECLINICAL RESEARCH DATABASE IN THE U.K., 2013-2016
  • FIGURE 33: CHINA: THE FASTEST-GROWING COUNTRY IN THE ASIA-PACIFIC MICE MODEL MARKET DURING THE FORECAST PERIOD
  • FIGURE 34: ONCOLOGY STUDIES TO DOMINATE THE ROW MICE MODEL MARKET, BY APPLICATION
  • FIGURE 35: MAJOR PLAYERS FOCUSED ON INORGANIC GROWTH STRATEGIES (2013-2016)
  • FIGURE 36: GLOBAL MICE MODEL MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 37: BATTLE FOR MARKET SHARE: ALLIANCES, AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS FORMED THE KEY GROWTH STRATEGY
  • FIGURE 38: ALLIANCES, COLLABORATIONS, AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS (2013-2016), BY COMPANY
  • FIGURE 39: KEY PLAYERS FOCUSING ON GRANTS & FUNDS (2013-2016)
  • FIGURE 40: KEY PLAYERS FOCUSING ON EXPANSIONS (2013-2016)
  • FIGURE 41: KEY PLAYERS FOCUSING ON PRODUCT LAUNCHES (2013-2016)
  • FIGURE 42: KEY PLAYERS FOCUSING ON ACQUISITIONS (2013-2016)
  • FIGURE 43: KEY PLAYERS FOCUSING ON LICENSING (2013-2016)
  • FIGURE 44: KEY PLAYERS FOCUSING ON OTHER STRATEGIES (2013-2016)
  • FIGURE 45: BUSINESS FOCUS OF THE TOP 3 MARKET PLAYERS
  • FIGURE 46: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 47: THE JACKSON LABORATORY: COMPANY SNAPSHOT (2015)
  • FIGURE 48: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2015)
  • FIGURE 49: TRANS GENIC, INC.: COMPANY SNAPSHOT (2015)
Back to Top